Intimal hyperplasia and arteriovenous fistula failure: looking beyond size differences

RI Vazquez-Padron, JC Duque, M Tabbara… - Kidney360, 2021 - journals.lww.com
The development of venous intimal hyperplasia (IH) has been historically associated with
failure of arteriovenous fistulas (AVFs) used for hemodialysis. This long-standing …

[HTML][HTML] Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access …

DM DePietro, SO Trerotola - Cardiovascular Diagnosis and …, 2023 - ncbi.nlm.nih.gov
Methods An electronic search was performed on PubMed and EMBASE to identify relevant
randomized controlled trials (RCTs) comparing DCBs and plain balloon angioplasty from …

Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized …

C Luo, M Liang, Y Liu, D Zheng, Q He, J Jin - Renal Failure, 2022 - Taylor & Francis
Purpose To compare the efficacy and safety between paclitaxel coated balloon (PCB)
angioplasty and conventional balloon (CB) angioplasty in the treatment of dysfunctional …

Management of central venous stenoses and occlusions

P Kitrou, K Katsanos, D Karnabatidis - CardioVascular and Interventional …, 2023 - Springer
Symptomatic central venous stenosis and occlusion remains the gordian knot of vascular
access. Advances in techniques, like sharp recanalization, allowed for improved success …

Drug-coated balloons for the dysfunctional vascular access: an evidence-based road map to treatment and the existing obstacles

P Kitrou, K Katsanos, GA Georgopoulou… - Seminars in …, 2022 - thieme-connect.com
An underlying stenosis within the venous limb of a hemodialysis access circuit is the main
etiology for graft and fistula dysfunction as well as other symptoms such as arm, breast, and …

The role of drug-coated balloon in haemodialysis arteriovenous fistula stenosis management

K Da Zhuang, FG Irani, A Gogna, CW Too… - CardioVascular and …, 2023 - Springer
Arteriovenous fistula (AVF) stenosis is a common problem leading to dialysis access
dysfunction. The conventional balloon (CB) is the most commonly used device during …

Comparison of Clinical Efficacy and Safety of Drug-Coated Balloons versus Percutaneous Transluminal Angioplasty in Arteriovenous Fistulas: A Review of Systematic …

H Lee, H Choi, E Han, YJ Kim - Journal of Vascular and Interventional …, 2024 - Elsevier
Purpose A review of systematic reviews (SRs) and an update of the current meta-analysis
were conducted to evaluate the clinical efficacy and safety of drug-coated balloons (DCBs) …

Drug-coated balloons versus conventional percutaneous transluminal angioplasty for treatment-naïve dysfunctional arteriovenous fistulas. A 10-year single center …

A AlQubaisi, M Arabi, Y AlZahrani… - Saudi Medical …, 2024 - pmc.ncbi.nlm.nih.gov
Objectives: To compare the primary patency and restenosis rates in treatment naieve
dialysis arteriovenous fistulas (AVFs) after drug-coated balloons (DCB) versus plain balloon …

Endovascular tools for vascular access stenosis: Flow-chart proposal

M Taurisano, A Mancini, C Cortese… - The Journal of …, 2024 - journals.sagepub.com
Stenosis represents the most relevant arteriovenous fistula (AVF) pathology and can affects
the entire conduit forming the fistula, from afferent artery to central venous vessels …

Effectiveness of Initial and Repeat Drug-Coated Balloon Angioplasty of Restenotic Arteriovenous Fistulae Compared with That of Plain Angioplasty

N Fujimura, T Hattori, M Takahara, M Fujihara… - Journal of Vascular and …, 2024 - Elsevier
Purpose To evaluate the effect of drug-coated balloon (DCB) with high-dose paclitaxel for
the treatment of restenotic dysfunctional arteriovenous fistulae (AVFs). Materials and …